CXCR2 and colonic neoplasm: In analogy to mice with established colon tumors, treatment of Apcfl/fl‐Cdx2CreERT2 mice with combined anti‐Gr1 antibody and CXCR2 inhibitor during and after tumor initiation led to reduced tumor neutrophil infiltration and reduced tumor burden (Fig EV2).